Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.44M 1.33M 1.24M 2.33M 155M 2.38M 15.94M 6.17M 76.48M 6.16M 6.03M 265M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.13M 6.57M 6.15M 11.53M 767M 11.77M 78.96M 30.55M 379M 30.52M 29.86M 1.31B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
+7.13%+9.97%+55.80%+160.09% 1,077B
+3.99%+11.50%+67.09%+55.96% 613B
+4.20%+17.03%+38.97%+91.06% 448B
+0.99%+4.85%+28.17%+23.89% 332B
+1.82%+8.19%+40.04%+27.95% 293B
+0.22%+6.75%+31.30%+42.34% 286B
+0.73%+8.53%-27.33%-39.55% 215B
+1.56%+6.14%+29.30%+60.97% 193B
+3.26%+3.33%+15.55%+68.24% 159B
Average -7.56%+8.00%+30.99%+54.55% 401.79B
Weighted average by Cap. +3.85%+8.93%+41.75%+80.17%

Financials

2007 2008
Net sales 23.47M 20.58M 18.97M 17.76M 33.29M 2.21B 33.99M 228M 88.21M 1.09B 88.12M 86.19M 3.79B 25.96M 22.76M 20.98M 19.64M 36.83M 2.45B 37.6M 252M 97.58M 1.21B 97.48M 95.35M 4.2B
Net income -20.86M -18.29M -16.86M -15.78M -29.59M -1.97B -30.21M -203M -78.4M -972M -78.32M -76.61M -3.37B -4.01M -3.51M -3.24M -3.03M -5.68M -378M -5.8M -38.91M -15.06M -187M -15.04M -14.71M -648M
Net Debt 18.79M 16.48M 15.19M 14.22M 26.66M 1.77B 27.21M 183M 70.63M 876M 70.56M 69.02M 3.04B 6.49M 5.69M 5.24M 4.91M 9.21M 612M 9.4M 63.03M 24.39M 302M 24.36M 23.83M 1.05B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-